DK1709075T3 - Behandling af virusinfektioner - Google Patents

Behandling af virusinfektioner

Info

Publication number
DK1709075T3
DK1709075T3 DK04806160.0T DK04806160T DK1709075T3 DK 1709075 T3 DK1709075 T3 DK 1709075T3 DK 04806160 T DK04806160 T DK 04806160T DK 1709075 T3 DK1709075 T3 DK 1709075T3
Authority
DK
Denmark
Prior art keywords
treatment
virus infections
infections
virus
Prior art date
Application number
DK04806160.0T
Other languages
English (en)
Inventor
Curtis Dobson
Original Assignee
Ai2 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ai2 Ltd filed Critical Ai2 Ltd
Application granted granted Critical
Publication of DK1709075T3 publication Critical patent/DK1709075T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775Apolipopeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK04806160.0T 2003-12-17 2004-12-17 Behandling af virusinfektioner DK1709075T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0329254.7A GB0329254D0 (en) 2003-12-17 2003-12-17 Treatment of viral infections
PCT/GB2004/005360 WO2005058959A2 (en) 2003-12-17 2004-12-17 Treatment of viral infections

Publications (1)

Publication Number Publication Date
DK1709075T3 true DK1709075T3 (da) 2012-08-27

Family

ID=30471239

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04806160.0T DK1709075T3 (da) 2003-12-17 2004-12-17 Behandling af virusinfektioner

Country Status (11)

Country Link
US (3) US7691382B2 (da)
EP (2) EP1709075B9 (da)
JP (2) JP2007535910A (da)
CN (2) CN1894281B (da)
AU (1) AU2004299343B8 (da)
CA (1) CA2548585A1 (da)
DK (1) DK1709075T3 (da)
ES (1) ES2389078T3 (da)
GB (1) GB0329254D0 (da)
PL (1) PL1709075T3 (da)
WO (1) WO2005058959A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0329254D0 (en) * 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections
GB0329958D0 (en) * 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) * 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) * 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections
ES2543341T3 (es) 2005-09-13 2015-08-18 National Research Council Of Canada Métodos y composiciones para modular la actividad de células tumorales
PL2085774T3 (pl) * 2008-02-01 2018-08-31 Kraft Foods R & D, Inc. Sposób określania konsystencji materiału spożywczego
WO2009102715A2 (en) * 2008-02-11 2009-08-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Peptide therapy for ocular herpes infections
JP5553336B2 (ja) * 2008-02-14 2014-07-16 国立大学法人京都工芸繊維大学 ペプチド、当該ペプチドの用途及び生産方法並びに当該ペプチドが固定化された固相及びその生産方法
DK2504363T3 (da) 2009-11-24 2019-07-29 Alethia Biotherapeutics Inc Anti-clusterin-antistoffer og antigenbindende fragmenter og deres anvendelse til reducering af tumorvolumen
US20120053128A1 (en) * 2010-08-26 2012-03-01 Xavier University Method of inhibiting angiogenesis
WO2013013187A1 (en) 2011-07-21 2013-01-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Apolipoprotein e polypeptides and their use
EP2817028A4 (en) 2012-02-22 2015-11-04 Alethia Biotherapeutics Inc COMMON USE OF A CLUSTERIN INHIBITOR AND EGFR INHIBITOR FOR TREATING CANCER
US9636299B2 (en) 2012-03-29 2017-05-02 Xavier University Of Louisiana Method for treating diabetic retinopathy
KR20170065583A (ko) 2014-10-01 2017-06-13 플랜트 헬스 케어, 인코포레이티드 과민성 반응 유발제 펩타이드 및 이의 용도
US20170298100A1 (en) * 2014-10-01 2017-10-19 Cascadia Life Sciences Llc Anti-viral peptides
MX2017004278A (es) 2014-10-01 2018-03-28 Plant Health Care Inc Peptidos inductores que tienen una caja de respuesta de hipersensibilidad interrumpida y su uso.
US10793608B2 (en) 2016-04-06 2020-10-06 Plant Health Care, Inc. Hypersensitive response elicitor-derived peptides and use thereof
US11371011B2 (en) 2016-04-06 2022-06-28 Plant Health Care, Inc. Beneficial microbes for delivery of effector peptides or proteins and use thereof
JP2022532317A (ja) * 2019-04-30 2022-07-14 マックスウェル バイオサイエンシーズ,インコーポレイテツド ハロゲン化抗菌ペプトイド
CN116813712B (zh) * 2023-06-16 2024-03-29 东北农业大学 一种富含Trp的α-螺旋结构抗菌肽W33及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5473039A (en) * 1989-08-18 1995-12-05 The Scripps Research Institute Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
WO1993000443A1 (en) * 1991-06-26 1993-01-07 Bio-Technology General Corp. Purification of recombinant apolipoprotein e from bacteria
US5344822A (en) 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
JP2001518449A (ja) * 1997-09-30 2001-10-16 デューク・ユニバーシティー アポリポタンパク質e/成長因子複合体およびその使用法
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
GB0200757D0 (en) * 2002-01-15 2002-02-27 Univ Manchester Diagnostic methods
GB0329254D0 (en) * 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections

Also Published As

Publication number Publication date
AU2004299343B8 (en) 2012-02-23
WO2005058959A3 (en) 2005-12-15
AU2004299343A1 (en) 2005-06-30
EP1709075B1 (en) 2012-06-06
CN1894281A (zh) 2007-01-10
EP1709075B9 (en) 2012-10-24
US7691382B2 (en) 2010-04-06
PL1709075T3 (pl) 2012-11-30
CN1894281B (zh) 2012-10-03
AU2004299343B2 (en) 2011-03-10
CA2548585A1 (en) 2005-06-30
WO2005058959A2 (en) 2005-06-30
ES2389078T3 (es) 2012-10-23
CN102336815A (zh) 2012-02-01
JP2012115277A (ja) 2012-06-21
US20130150288A1 (en) 2013-06-13
US20070117746A1 (en) 2007-05-24
US20100221273A1 (en) 2010-09-02
JP2007535910A (ja) 2007-12-13
GB0329254D0 (en) 2004-01-21
EP1709075A2 (en) 2006-10-11
EP2277911A1 (en) 2011-01-26

Similar Documents

Publication Publication Date Title
DK1709075T3 (da) Behandling af virusinfektioner
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
DK1755661T3 (da) Gelsolin til anvendelse til behandling af infektioner
IS8476A (is) Lifrarbólgu C-veirutálmar
IS8475A (is) Lifrarbólgu C-veirutálmar
DK1776136T3 (da) Behandling af tilstande, der involverer demyelinisering
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
FI20060154A (fi) Neurogeneratiivisten tilojen hoito
DK1501921T4 (da) Forbedrede virusrensningsmetoder
DK1653807T3 (da) Anvendelse af dermale mikroorganer
DK1744781T3 (da) Behandling af infektionssygdomme
DE602004018587D1 (de) Staubschützende Wegwerfmaske
DK1438306T3 (da) Derivater af UK-2A
IS7851A (is) 1-asýl-pýrrólídínafleiður til að meðhöndla veirusýkingar
DK1732604T3 (da) Fremgangsmåder til behandling af hiv-infektion
DK1765288T3 (da) Tobramycinpræparater til behandling af endobronchiale infektioner
DE602005012267D1 (de) N von geräten
IS7530A (is) Lifrarbólgu C-veirutálmar
DK1912999T3 (da) Makrocykliske inhibitorer af hepatitis-c-virus
DK1912997T3 (da) Makrocycliske inhibitorer af hepatitis C virus
DK1912996T3 (da) Makrocykliske inhibitorer af hepatitis C-virus
DK1912981T3 (da) Makrocykliske inhibitorer af Hepatitis C-virus
DK1912995T3 (da) Makrocykliske inhibitorer af hepatitis C virus
DK1913014T3 (da) Makrocykliske inhibitorer af hepatitis-c-virus
DK1587542T3 (da) Anvendelse af anti-CD100-antistoffer